New Genetic Test Effectively Screens Newborns for Rare Disorders
A newly developed test to screen for three rare genetic disorders simultaneously in newborns was feasible, reliable, and scalable, recent research shows.
Read MorePosted by Andy Lundin | Jan 25, 2022 | Molecular Diagnostics |
A newly developed test to screen for three rare genetic disorders simultaneously in newborns was feasible, reliable, and scalable, recent research shows.
Read MorePosted by Chris Wolski | Nov 24, 2021 | Diabetes & Metabolic Diseases |
Siemens Healthineer’s ELF Test performed the best of the five blood biomarkers selected for the FNIH NIMBLE Study.
Read MorePosted by Chris Wolski | Oct 22, 2021 | Diabetes & Metabolic Diseases |
New research creates a road map for future treatments of nonalcoholic fatty liver disease and confirms the need for more mainstream screening.
Read MorePosted by Chris Wolski | Aug 30, 2021 | Diabetes & Metabolic Diseases |
Testing for, monitoring, and controlling diabetes continues to become more robust, cost-effective, and nuanced.
Read MorePosted by Chris Wolski | Aug 24, 2021 | Unknown Origin & Other Cancer Types |
Siemens Healthineers’ Enhanced Liver Fibrosis (ELF) Test was granted marketing authorization under the De Novo review pathway.
Read More